Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

• Status: Completed
• Trial end date: 2006-04-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to test the safety and effectiveness of the Investigational Drug on insomnia.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: H. Lundbeck A/S
• Treatments: Gaboxadol

Criteria

Inclusion Criteria:

• Adult patients with a diagnosis of primary insomnia and in good physical and mental health

Exclusion Criteria:

• Adult patients with other medical , neurological and sleep disorders